Abstract
Adenylate cyclase activity was assayed in rat striatal homogenates. Dopamine and, to a lesser extent, 1-norepinephrine added in vitro produced a dose-dependent enhancement of adenylate cyclase activity. Fluphenazine did not alter basal enzyme activity, but prevented both dopamine- and 1-norepinephrine-elicited increases. No significant changes in basal- or dopamine-stimulated adenylate cyclase activity were found in homogenates from rats pretreated with chlorpromazine for 21 days or reserpine for 2 days. It is concluded that the behavioral and neurophysiologic postsynaptic supersensitivities that follow similar pretreatments are not mediated by alterations in the sensitivity of striatal adenylate cyclase to dopamine.
Original language | English |
---|---|
Pages (from-to) | 563-568 |
Number of pages | 6 |
Journal | Life Sciences |
Volume | 17 |
Issue number | 4 |
DOIs | |
State | Published - 15 Aug 1975 |
Externally published | Yes |